Petras Michael B. Jr. sold 850,000 shares of Sotera Health Co at $18.50 for −$15.7M on Aug 17, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Executive Chairman
Executive Chairman
Filed Aug 19, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$15,725,935Shares × reported price
Shares traded
850,000Common Stock
Price per share
$18.50Reported price. Read footnotes for ranges.
% of reported position traded
17.64%This security and ownership context
Holdings after
3,969,393Indirect · By Grantor Trust
Trade date
Aug 17, 2026Sell
Filed
Aug 19, 2026, 4:24 PM ET2-day reporting delay
Accession
0001193125-26-356962Code S · Transaction 11137
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 4,819,393 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 17, 2026Sell294,515$18.50−$5,448,851.47Trade 11136
2 transaction rows in this filing. Joint filers share the same rows.

SHC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
SHC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.6%1w ago −0.2%1d ago −0.6%
Returns since7d +2.8%30d −0.3%90d180d1y

Footnotes in full

F1: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.